New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn Combo Vial: BPC 157 TB 500 (20mg vials) Peptide Partners